Ri-Zhen Huang

1.6k total citations
79 papers, 1.3k citations indexed

About

Ri-Zhen Huang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ri-Zhen Huang has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 33 papers in Organic Chemistry and 19 papers in Oncology. Recurrent topics in Ri-Zhen Huang's work include Synthesis and biological activity (21 papers), Natural product bioactivities and synthesis (16 papers) and Metal complexes synthesis and properties (13 papers). Ri-Zhen Huang is often cited by papers focused on Synthesis and biological activity (21 papers), Natural product bioactivities and synthesis (16 papers) and Metal complexes synthesis and properties (13 papers). Ri-Zhen Huang collaborates with scholars based in China, Bangladesh and Norway. Ri-Zhen Huang's co-authors include Heng‐Shan Wang, Xiaochao Huang, Ying-Ming Pan, Zhi‐Xin Liao, Guiyang Yao, Zhimei Wang, Shaohua Gou, Zhi‐Xin Liao, Dong Liang and Gui-Bin Liang and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Ri-Zhen Huang

72 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ri-Zhen Huang

Since Specialization

Citations

This map shows the geographic impact of Ri-Zhen Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ri-Zhen Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ri-Zhen Huang more than expected).

Fields of papers citing papers by Ri-Zhen Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ri-Zhen Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ri-Zhen Huang. The network helps show where Ri-Zhen Huang may publish in the future.

Co-authorship network of co-authors of Ri-Zhen Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Ri-Zhen Huang. A scholar is included among the top collaborators of Ri-Zhen Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ri-Zhen Huang. Ri-Zhen Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance 2025 ·Journal of Medicinal Chemistry ·Meng Wang, Guimei Li, (unknown), (unknown), (unknown), Ri-Zhen Huang, (unknown), Guiping Chen, Zhikun Liu, Ye Zhang, Heng‐Shan Wang, Xiaochao Huang	0
2	Curcumin Modulates TIGIT/Neuropilin-1 to Regulate T-Cell Immune Homeostasis in Ulcerative Colitis 2025 ·Foods ·(unknown), Jiaqi Huang, (unknown), Leilei Fu, Ri-Zhen Huang, (unknown), (unknown), Youbao Zhong, Duan‐Yong Liu, Haimei Zhao	0
3	Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer 2024 ·Bioorganic Chemistry ·Qiaoling Liang, (unknown), (unknown), Xiaoqun Zhou, (unknown), Jian-Hua Wei, (unknown), Xian‐Li Ma, Ye Zhang, Ri-Zhen Huang	5
4	Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis 2024 ·Bioorganic Chemistry ·(unknown), Simin Liang, (unknown), Ri-Zhen Huang, Yanyan Chen, Ye Zhang, Yanli Xü	8
5	Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects 2023 ·Molecules ·Ri-Zhen Huang, Qiaoling Liang, (unknown), Ke Wang, Huiyong Zhang, Heng‐Shan Wang, Xian‐Li Ma, Jian-Hua Wei, Ye Zhang	7
6	Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance 2023 ·European Journal of Medicinal Chemistry ·Simin Liang, Gui-Bin Liang, Huiling Wang, (unknown), Xian‐Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang	14
7	Discovery of novel sulfonamide chromone-oxime derivatives as potent indoleamine 2,3-dioxygenase 1 inhibitors 2023 ·European Journal of Medicinal Chemistry ·Ke Wang, (unknown), Qiaoling Liang, Ye Zhang, Xian‐Li Ma, Qi Wang, Huiyong Zhang, (unknown), Jian-Hua Wei, Ri-Zhen Huang	9
8	Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists 2021 ·European Journal of Medicinal Chemistry ·(unknown), Mei Su, (unknown), Dezhong Wang, (unknown), (unknown), (unknown), Mu-xuan Wang, (unknown), (unknown), (unknown), Bo Sun, (unknown), Jin Qiu, Ri-Zhen Huang, Zhi‐Xin Liao	6
9	Anti-proliferative effects of diterpenoids from Sagittaria trifolia L. tubers on colon cancer cells by targeting the NF-κB pathway 2020 ·Food & Function ·(unknown), Ying Du, (unknown), (unknown), (unknown), (unknown), Yan Feng, (unknown), Bo Sun, Yan Li, Zhi‐Xin Liao, Ri-Zhen Huang	6
10	Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents 2020 ·European Journal of Medicinal Chemistry ·Xiaochao Huang, Meng Wang, (unknown), Jing Kong, Haijiang Zhang, Chunhao Yu, Yanming Wang, Heng‐Shan Wang, Ri-Zhen Huang	20
11	Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration 2019 ·MedChemComm ·Ri-Zhen Huang, Gui-Bin Liang, (unknown), Yilin Fang, (unknown), Meimei Zhou, Zhi‐Xin Liao, Jing Sun, Heng‐Shan Wang	27
12	A pentacyclic triterpene derivative possessing polyhydroxyl ring A suppresses growth of HeLa cells by reactive oxygen species-dependent NF-κB pathway 2018 ·European Journal of Pharmacology ·Ri-Zhen Huang, Le Jin, (unknown), (unknown), Ying Du, (unknown), Min Ji, Zhi‐Xin Liao, Heng‐Shan Wang	10
13	Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents 2018 ·European Journal of Medicinal Chemistry ·Wenbin Kuang, Ri-Zhen Huang, Jiao-Lan Qin, Xing Lü, Qi‐Pin Qin, Bi‐Qun Zou, Zhen‐Feng Chen, Hong Liang, Ye Zhang	25
14	New inhibitors of matrix metalloproteinases 9 (MMP-9): Lignans from Selaginella moellendorffii 2018 ·Fitoterapia ·Yuan Zhu, Ri-Zhen Huang, (unknown), (unknown), (unknown), Dong Liang, Heng‐Shan Wang	14
15	Side chain-functionalized aniline-derived ursolic acid derivatives as multidrug resistance reversers that block the nuclear factor-kappa B (NF-κB) pathway and cell proliferation 2017 ·MedChemComm ·Ri-Zhen Huang, (unknown), Zhi‐Xin Liao, Xiaochao Huang, Heng‐Shan Wang	12
16	Three new C-27-carboxylated-lupane-triterpenoid derivatives from Potentilla discolor Bunge and their in vitro antitumor activities 2017 ·PLoS ONE ·Jing Zhang, Chao Liu, Ri-Zhen Huang, Huifeng Chen, Zhi‐Xin Liao, Jinyue Sun, Xuekui Xia, Fengxiang Wang	15
17	Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation 2017 ·European Journal of Medicinal Chemistry ·Ri-Zhen Huang, Gui-Bin Liang, Xiaochao Huang, Bin Zhang, Meimei Zhou, Zhi‐Xin Liao, Heng‐Shan Wang	30
18	Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents 2017 ·European Journal of Medicinal Chemistry ·Xiaochao Huang, Ri-Zhen Huang, (unknown), Shaohua Gou, Heng‐Shan Wang	33
19	Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents 2015 ·European Journal of Medicinal Chemistry ·(unknown), Ri-Zhen Huang, (unknown), Ying-Ming Pan, Guiyang Yao, Ye Zhang, Heng‐Shan Wang	59
20	Synthesis and antitumor activity evaluation of maleopimaric acid N-aryl imide atropisomers 2013 ·Bioorganic & Medicinal Chemistry Letters ·Guiyang Yao, (unknown), Ri-Zhen Huang, Yajun Li, Yongtao Zhu, Ying-Ming Pan, Zhi‐Xin Liao, Heng‐Shan Wang	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact